European shares rebounded on Tuesday from a two-month low touched in the previous session, while the market braced for an ...

Novo Nordisk’s stocks experienced the sharpest monthly decline since July 2002 due to growing competition and several ...

US President Donald Trump is set to unveil reciprocal tariffs on Wednesday, with ongoing uncertainties surrounding his policies weighing on market sentiment. European stock markets posted their first ...

As Novo Nordisk A/S shares head for their worst month in more than two decades, the days when the Danish drugmaker was valued ...

As Novo Nordisk A/S shares head for their worst month in more than two decades, the days when the Danish drugmaker was valued at more than $600 billion are becoming a distant memory.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Danish drugmaker Novo Nordisk has been dethroned by German software giant SAP as Europe’s most valuable company. SAP has ...

Novo Nordisk shares are experiencing a significant decline amidst intensified investor concerns over its competitiveness in ...

Digital independence for Europe looks like an uphill climb. The U.S. still leads the way, and the catchup for Europe would ...

In September 2023, the Danish pharmaceutical business became the most valuable company in Europe by market capitalization due ...

The proposed UK assisted dying law may be delayed until 2029, raising doubts about its future. Novo Nordisk's shares tumble ...